Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Long

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Cancers|July 9, 2022
Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) ComponentsRama Soundararajan, Paul Viscuse, Patrick Pilie, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2009
Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virusCarole R Baskin, Helle Bielefeldt-Ohmann, Terrence M Tumpey, et al.
JAMA Network Open|April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T TherapyJames P Long, Rishab Prakash, Paul Edelkamp, et al.
JCI Insight|July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restorationMartina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Ebiomedicine|December 1, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trialXiaotao Zhang, Ehsan Irajizad, Kristi L Hoffman, et al.
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
NPJ Genomic Medicine|May 23, 2026
Germline variants in cancer susceptibility genes among patients with mucosal melanomaAfsaneh Amouzegar, Xiaogang Wu, James P Long, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Cancers|July 9, 2022
Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) ComponentsRama Soundararajan, Paul Viscuse, Patrick Pilie, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2009
Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virusCarole R Baskin, Helle Bielefeldt-Ohmann, Terrence M Tumpey, et al.
JAMA Network Open|April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T TherapyJames P Long, Rishab Prakash, Paul Edelkamp, et al.
JCI Insight|July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restorationMartina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Ebiomedicine|December 1, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trialXiaotao Zhang, Ehsan Irajizad, Kristi L Hoffman, et al.
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
NPJ Genomic Medicine|May 23, 2026
Germline variants in cancer susceptibility genes among patients with mucosal melanomaAfsaneh Amouzegar, Xiaogang Wu, James P Long, et al.
Pageof 9